The IDM - a cross-faculty, multidisciplinary postgraduate health research institute
Based on the UCT Faculty of Health Sciences campus in a 7,100 sqm state-of-the-art facility, we operate in the fields of infectious diseases and molecular medicine.
Clinical Research
Clinical research relevant to the needs of Africa's people
The IDM influences health policy and practice by translating our scientific discoveries and applying them in various communities; community relationships and trust are critical.
IDM Capacity Building
Capacity building in the IDM
The largest research entity at UCT, the IDM is a national leader in research and health sciences human capital development.
Cell Imaging Microscope
IDM driving world class research
We conduct research at the laboratory-clinic-community interface by engaging a wide range of scientific and clinical disciplines; with 62 consortia linking us with 183 institutions in 22 African countries and 24 countries beyond.

University accredited research institute - Tackling diseases of importance in Africa - Developing people - Impacting health policy and practice

Home > Home


Monday, 27 January 2020
HIV factor in kidney transplants: research sheds new light on risks

South Africa has one of the highest incidences of HIV in the world. More than 7 million people in the country are living with HIV. This high prevalence rate has led scientists in the country to explore solutions for a wide range of clinical problems that HIV-positive patients face, including end stage kidney failure.

Publication Date:
Thu, 28 Nov 2019 - 14:15
UCT – A global leader in HIV research

The global information analytics business, Elsevier, has released a report “based on global field-weighted citation impact” that has the University of Cape Town (UCT) coming out tops.

Publication Date:
Thu, 28 Nov 2019 - 14:00
International-level research at Postgrad Awards

The Institute of Infectious Disease and Molecular Medicine (IDM) hosted the award ceremony for the annual Postgraduate Student Publication Competition this week. The applications were judged by representatives of the International Scientific Advisory Committee (ISAC).

Publication Date:
Thu, 21 Nov 2019 - 08:45
Collaboration pushes frontiers of anti-malaria drug regimes

More than 200 million people around the world suffered from malaria in 2017. Over 400,000 died. The vast majority – around 90% – were in Africa, where many are all too familiar with the devastating impact of the disease. Young children and pregnant women are the most vulnerable.

Publication Date:
Thu, 21 Nov 2019 - 08:30